https://agdx.heemoetjeditzien.nl/nl/new-standard-for-obesity-and-dyslipidemia/2022-10-19T19:59:50+02:00https://agdx.heemoetjeditzien.nl/nl/obesity-panel/2022-11-09T09:25:17+01:00https://agdx.heemoetjeditzien.nl/nl/a-specific-mep-panel-for-research-purposes/2022-11-09T09:35:39+01:00https://agdx.heemoetjeditzien.nl/nl/epigenetic-test/2023-02-28T11:14:57+01:00https://agdx.heemoetjeditzien.nl/nl/dyslipidemia-panel/2022-11-09T09:30:14+01:00https://agdx.heemoetjeditzien.nl/nl/the-expert-consensus-panel-recommends-familial-hypercholesterolemia-genetic-testing/2022-10-19T19:59:50+02:00https://agdx.heemoetjeditzien.nl/nl/introducing-amsterdam-umc/2022-11-09T10:06:56+01:00https://agdx.heemoetjeditzien.nl/nl/study-validates-clinical-utility-of-episign-for-diagnosing-rare-heritable-disorders/2022-07-07T17:49:24+02:00https://agdx.heemoetjeditzien.nl/nl/elpag-award-lecture-2022/2023-01-09T11:07:35+01:00https://agdx.heemoetjeditzien.nl/nl/verhuizing-agdx/2025-03-07T12:35:45+01:00